Brompheniramine maleate 6 mg 12HR Extended Release Oral Tablet
RxNorm 359281
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 359281 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: brompheniramine maleate 6 mg 12HR Extended Release Oral Tablet.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCDPrescribable
Semantic Clinical Drug (SCD):
12 HR brompheniramine maleate 6 mg Extended Release Oral Tablet
(Atom ID: 12332158)
SYPrescribable
Synonym (SY):
Brompheniramine maleate 6 mg 12 HR Extended Release Oral Tablet
(Atom ID: 11797032)
PSNPrescribable
Prescribable Name (PSN):
Brompheniramine maleate 6 mg 12HR Extended Release Oral Tablet
(Atom ID: 6359841)
Patient Education
Brompheniramine
Brompheniramine relieves red, irritated, itchy, watery eyes; sneezing; and runny nose caused by allergies, hay fever, and the common cold. Brompheniramine helps control symptoms, but does not treat the cause of the symptoms or speed recovery. Brompheniramine should not be used to cause sleepiness in children. Brompheniramine is in a class of medications called antihistamines. It works by blocking the action of histamine, a substance in the body that causes allergic symptoms.
[Learn More]
* Please review the disclaimer below.